LBF20503SC01
| LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
| IDs and Links | |
|---|---|
| LipidBank | DFA0220 |
| LipidMaps | LMFA01030181 |
| CAS | |
| KEGG | {{{KEGG}}} |
| KNApSAcK | {{{KNApSAcK}}} |
| mol | LBF20503SC01 |
| EPA | |
|---|---|
| |
| Structural Information | |
| cis-5, cis-8, cis-11, cis-14, cis-17-Eicosapentaenoic acid | |
| |
| EPA / C20:5n-3 / C20:5 omega 3 | |
| Formula | C20H30O2 |
| Exact Mass | 302.224580204 |
| Average Mass | 302.451 |
| SMILES | C(CC=CCC=CCC=CCC=CCCCC(O)=O)=CCC |
| Physicochemical Information | |
| -54.4 to -53.8 °C | |
| 1.4977 at 23 °C | |
| soluble in heptane and methyl alcohol. | |
| Present in fish oils as an acylglycerol and animal phospholipids. Cattle-liver lipids; various fish and seal oils. | |
| Metabolic product of alpha -linolenic acid (9,12,15-18:3). The synthesis of 5,8,11,14,17-20:5 (=EPA) occurs via the following reaction sequence in the endoplasmic reticulum Sprecher_H et al.: 9,12,15-18:3 --> 6,9,12,15-18:4 --> 8,11,14,17-20:4 --> 5,8,11,14,17-20:5 --> 7,10,13,16,19-22:5. EPA is further metabolized to DHA. Precursor of PG3 series of prostaglandins. | |
| Considered to be the major reason for the beneficial effects of fish oils on the cardiovascular system. EPA is a precursor to series 3 eicosanoids that promote dilation of blood vessels and a slower blood clotting reaction and, as such, has been found to be critical to the maintenance of normal cardiovascular health. Bang_HO et al. Dyerberg_J et al. | |
| Spectral Information | |
| Mass Spectra | ""METHYL ESTER:316,300,287,262,247,234,215,201,180,161,152 "" Karlsson_KA et al. |
| UV Spectra | |
| IR Spectra | |
| NMR Spectra | ""METHYL ESTER: |
| Other Spectra | |
| Chromatograms | Gas liquid chromatogram  (provided by Dr. Akiko Horiuchi). |
| Reported Metabolites, References | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
